An enzyme-linked immunosorbent assay was performed directly on fixed, virus-infected cell monolayers to rapidly determine the susceptibility of herpes simplex virus to antiviral drugs. Susceptibility determinations by this method correlated well with those obtained by plaque reduction assay and avoided some of the drawbacks of other methods currently available.
acyclovir (acycloguanosine; 9-[(2-hydroxyethoxy)methyl] guanine) or 9-(1,3-hydroxy-2-propoxymethyl)guanine (DHPG; Burroughs Wellcome Co., Research Triangle Park, N.C.) diluted in 0.1 ml of Dulbecco minimal essential medium with supplements at twice the desired final concentrations (micrograms per milliliter) of 0.06, 0.125, 0.25, 0.5, 1.0, and 10.0. Uninfected wells and infected wells without antiviral agents served as tissue and virus controls, respectively. The ELISA was performed at 24 or 48 h after infection when three or more plaques per well were seen on a brief examination of the virus control wells.
The assay was initiated by washing the monolayers with phosphate buffered saline containing 1% bovine serum albumin and fixing them in situ with 0.2 ml of 0.05% glutaraldehyde for 20 min at 4°C. We then sequentially added polyclonal rabbit anti-HSV immunoglobulin (1/2,000) (Accurate Chemicals, Westbury, N.Y.) for 1 h, peroxidase-conjugated goat anti-rabbit immunoglobulin G antibody (1/2,000) (TAGO, Inc., Burlingame, CA) for 2 h, and the substrate. Intervening washes were done with phosphate buffered saline containing 0.05% Tween 20 and 1% bovine serum albumin. The substrate was 1.0 mg of the diammonium salt of 2,2'-azinobis(3-ethylbenzthiazoline-6-sulfonic acid) (Sigma Chemical Co., St. Louis, Mo.) per ml in phosphatecitrate buffer (pH 4.8) with 0.005% hydrogen peroxide. In the presence of peroxidase, the substrate changes from light to dark green. The A405 of the wells was read at room temperature with a Bio-Tek EIA reader (model EL 307; Bio-Tek Instruments, Inc., Burlington, Vt.) when the A405 of the virus control was 1.0 to 1.4. The susceptibility to antiviral agents was expressed as the 50% inhibitory dose (ID50), i.e., the concentration of drug that reduced the A405 to 50% of that of the virus control.
Because the sensitivity of an ELISA used to determine antiviral susceptibility is dependent on the antigen generated in the virus control wells, preliminary experiments were performed to determine the relationship at various times after infection between virus inoculum and the A405. With a laboratory strain of HSV type 2 (HSV-2) (434D), HSV replication could be reliably detected at 24 h with an inoculum as low as 200 PFU per well and at 48 h with an inoculum of 25 PFU per well (Fig. 1) . HSV-1 and HSV-2 could be detected by using rabbit antibody to either serotype.
The effect of inoculum size and duration of incubation on ID50 was assessed by infecting duplicate sets of plates with 30, 300, or 3,000 PFU of HSV 434D per well in the presence of acyclovir. The Plate-to-plate variability was studied for strain 434D and two clinical HSV-2 isolates (strains 1402 and 771) by performing triplicate assays on the same day with an inoculum of 300 PFU per well. This test resulted in a plate-to-plate variation in ID50 of 27, 18, and 14%, respectively. At any acyclovir concentration, the mean well-to-well percent coefficient of variation of A405 for these three isolates was 11, 10, and 5%, respectively (data not shown).
Acyclovir ID50 results for 15 additional stock HSV isolates for which titers had been determined (nine isolates of HSV-2 and six isolates of HSV-1, provided by S. Lehrman, Burroughs Wellcome) were then determined by both ELISA and plaque reduction assay (PRA) ( Table 1) . Three of the four isolates with an ID50 by ELISA of >10.0 ,ug/ml also had an ID50 by PRA of >10.0 ,ug/ml. The fourth isolate had an ID50 by PRA of 3.0 ,ug/ml. These four isolates were considered resistant to acyclovir. Excluding these four isolates, values determined by the two methods correlated well (correlation coefficient, 0.80). The ID50 of DHPG for strain 434D was 0.05 ,ug/ml by ELISA and 0.06 ,ug/ml by PRA. (2, 4) . Our ELISA also has advantages over nucleic acid hybridization (3) and [125I] iododeoxycytidine uptake (9) by avoiding the need for nucleic acid probes and radioisotopes.
Two previous works describe the application of ELISA methods to HSV susceptibility testing. In the first report (5) , only a single HSV-1 isolate for which titers had been determined was studied, and no ID50 was determined. The second report (10) 
